# Avistone

**Canonical:** https://apis.io/providers/avistone/  
**Website:** https://en.avistonebio.com  
**APIs profiled:** 0

Beijing Avistone Biotechnology Co., Ltd. is a commercial-stage innovative biopharmaceutical company headquartered in Beijing, China, focused on the research, development, and commercialization of first-in-class and best-in-class oncology therapies. Founded in 2012 (originally Beijing Pearl Biotechnology) and renamed Avistone in 2018, the company has two approved cancer drugs on the market: Vebreltinib (万比锐®), a MET inhibitor approved for non-small cell lung cancer and glioma indications and included in China's National Reimbursement Drug List, and Andamertinib (安比锐®), an EGFR exon 20 insertion inhibitor approved in 2026 for advanced NSCLC. Avistone maintains a pipeline of additional candidates (ANS01 through ANS09) across solid-tumor indications and is backed by IDG Capital. The company publishes no public developer API or programmatic surface; this profile captures its corporate and investor identity.

## Kin Score — 5.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 5.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 5.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Healthcare, Biopharmaceutical, Oncology, Pharmaceuticals, Drug Development, Biotechnology, Cancer Therapeutics, China

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/avistone/). Scores are computed from the provider's own public artifacts under a published rubric.